Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Christen

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxelM M de las Alas, R D Christen, D P Gately, et al.
The Lancet. Oncology|July 17, 2015
CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 studyPhilippe A Cassier, Antoine Italiano, Carlos A Gomez-Roca, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Cancer Chemotherapy and Pharmacology|May 10, 2000
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxelM M de las Alas, R D Christen, D P Gately, et al.
The Lancet. Oncology|July 17, 2015
CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 studyPhilippe A Cassier, Antoine Italiano, Carlos A Gomez-Roca, et al.
Pageof 8